# Eli Lilly (LLY) earnings: $20.64B in 2025, 19-year history

URL: https://funkfolio.com/stock/LLY/earnings

> Eli Lilly (LLY) earnings were $20.64B in fiscal 2025, up 94.9% from fiscal 2024. Over five fiscal years it grew 27.2% a year.

---

## Eli Lilly (LLY) earnings

**Earnings (net income) · fiscal 2025:** $20.64B year ended Dec 31, 2025

Eli Lilly (LLY) reported net income of $20.64B in fiscal 2025 (the year ended December 31, 2025). That is 94.9% higher than the $10.59B of fiscal 2024. Figures as of 18 Nov 2026, 05:35 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Earnings (net income), fiscal 2025:** $20.64B
- **Change on fiscal 2024:** +94.9%
- **Growth, 5 years:** +27.2% a year
- **Growth, 10 years:** +24.0% a year
- **Highest on record:** $20.64B fiscal 2025
- **Lowest on record:** -$2.07B fiscal 2008
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 05:35 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Eli Lilly earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 27.2% a year; over ten years the rate was 24.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $20.64B in fiscal 2025 and the lowest -$2.07B in fiscal 2008.

### Earnings (net income) by fiscal year

### Eli Lilly earnings, year by year

Eli Lilly (LLY) earnings by fiscal year

| Fiscal year | Earnings (net income) | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $20.64B | 94.9% up | Dec 31, 2025 |
| 2024 | $10.59B | 102.1% up | Dec 31, 2024 |
| 2023 | $5.24B | 16.1% down | Dec 31, 2023 |
| 2022 | $6.24B | 11.9% up | Dec 31, 2022 |
| 2021 | $5.58B | 9.9% down | Dec 31, 2021 |
| 2020 | $6.19B | 25.5% down | Dec 31, 2020 |
| 2019 | $8.32B | 157.4% up | Dec 31, 2019 |
| 2018 | $3.23B | — | Dec 31, 2018 |
| 2017 | -$204.10M | 107.5% down | Dec 31, 2017 |
| 2016 | $2.74B | 13.7% up | Dec 31, 2016 |
| 2015 | $2.41B | 0.7% up | Dec 31, 2015 |
| 2014 | $2.39B | 49.0% down | Dec 31, 2014 |
| 2013 | $4.68B | 14.6% up | Dec 31, 2013 |
| 2012 | $4.09B | 6.0% down | Dec 31, 2012 |
| 2011 | $4.35B | 14.2% down | Dec 31, 2011 |
| 2010 | $5.07B | 17.1% up | Dec 31, 2010 |
| 2009 | $4.33B | — | Dec 31, 2009 |
| 2008 | -$2.07B | 170.2% down | Dec 31, 2008 |
| 2007 | $2.95B | — | Dec 31, 2007 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

### How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

### Eli Lilly, figure by figure

- [Eli Lilly market cap](https://funkfolio.com/stock/LLY/market-cap)
- [Eli Lilly revenue](https://funkfolio.com/stock/LLY/revenue)
- [Eli Lilly earnings per share (EPS)](https://funkfolio.com/stock/LLY/eps)
- [Eli Lilly P/E ratio](https://funkfolio.com/stock/LLY/pe-ratio)
- [Eli Lilly P/S ratio](https://funkfolio.com/stock/LLY/ps-ratio)
- [Eli Lilly P/B ratio](https://funkfolio.com/stock/LLY/pb-ratio)
- [Eli Lilly free cash flow](https://funkfolio.com/stock/LLY/free-cash-flow)
- [Eli Lilly operating margin](https://funkfolio.com/stock/LLY/operating-margin)
- [Eli Lilly dividend](https://funkfolio.com/stock/LLY/dividend)
- [Eli Lilly shares outstanding](https://funkfolio.com/stock/LLY/shares-outstanding)
- [Eli Lilly total debt](https://funkfolio.com/stock/LLY/total-debt)
- [Eli Lilly cash on hand](https://funkfolio.com/stock/LLY/cash)
- [Eli Lilly total assets](https://funkfolio.com/stock/LLY/total-assets)
- [Eli Lilly return on equity (ROE)](https://funkfolio.com/stock/LLY/roe)
- [Eli Lilly return on invested capital (ROIC)](https://funkfolio.com/stock/LLY/roic)

[Eli Lilly (LLY) overview: price, valuation and scorecard](https://funkfolio.com/stock/LLY) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Eli Lilly earnings: questions and answers

**What is Eli Lilly's net income?**

Eli Lilly (LLY) reported net income of $20.64B in fiscal 2025 (the year ended December 31, 2025). That is 94.9% higher than the $10.59B of fiscal 2024.

**What is the growth rate of Eli Lilly's net income?**

Over the five fiscal years to 2025 net income grew at a compound 27.2% a year; over ten years the rate was 24.0% a year.

**What are the highest and lowest net income figures on record for Eli Lilly?**

Across the 19 fiscal years on record (2007–2025), the highest was $20.64B in fiscal 2025 and the lowest -$2.07B in fiscal 2008.

**How is Eli Lilly's net income calculated?**

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

### Learn: earnings

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Eli Lilly (LLY) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/LLY/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.
